BMJ Case Reports

Acute necrotising pancreatitis in a patient with Behçet’s disease

A man in his 40s of Middle Eastern descent, with no prior medical history, presented with severe abdominal pain that had ...
Nasdaq

FDA Grants Soligenix Orphan Drug Designation for the Treatment of Behçet's Disease after Reviewing Recent Phase 2 Clinical Study Results

PRINCETON, N.J., Aug. 18, 2025 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to ...
Nasdaq

Soligenix Announces Formation of Behçet's Disease Medical Advisory Board

PRINCETON, N.J., Feb. 8, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to ...
MarketWatch

Soligenix Shares Surge on FDA Orphan Designation in Behcet's

Soligenix shares surged more than 50% in early trading Monday after the late-stage biopharmaceutical company won U.S. Food and Drug Administration orphan-drug designation for the active ingredient in ...